Advanced search×

Monoclonal gammopathy of undetermined significance (MGUS) and smoldering (asymptomatic) multiple myeloma: IMWG consensus perspectives risk factors for progression and guidelines for monitoring and management.

R A RA Kyle, B G M BG Durie, S V SV Rajkumar, O O Landgren, J J Blade, G G Merlini, N N Kröger, H H Einsele, D H DH Vesole, M M Dimopoulos, J J San Miguel, H H Avet-Loiseau, R R Hajek, W M WM Chen, K C KC Anderson, H H Ludwig, P P Sonneveld, S S Pavlovsky, A A Palumbo, P G PG Richardson, B B Barlogie, P P Greipp, R R Vescio, I I Turesson, J J Westin, M M Boccadoro, and

Leukemia 24(6):1121-7 (2010) PMID 20410922

Monoclonal gammopathy of undetermined significance (MGUS) was identified in 3.2% of 21 463 residents of Olmsted County, Minnesota, 50 years of age or older. The risk of progression to multiple myeloma, Waldenstrom's macroglobulinemia, AL amyloidosis or a lymphoproliferative disorder is approximately 1% per year. Low-risk MGUS is characterized by having an M protein

Referenced by 1 articles

DOI: 10.1038/leu.2010.60
Version: za2963e q8za1 q8zb6 q8zc8 q8zd9 q8ze7 q8zf1 q8zgd

Similar articles you may find interesting…

  1. Opportunistic Infections With Anti-Tumor Necrosis Factor-α Therapy in Inflammatory Bowel Disease: Meta-Analysis of Randomized Controlled Tri...
    Alexander C Ford and Laurent Peyrin-Biroulet

    Am J Gastroenterol (2013) PMID 23649185

    Anti-TNF therapy doubles the risk of opportunistic infections in inflammatory bowel disease patients. This underlines the importance of adherence to guidelines for their prevention and management.Am J Gastroenterol advance online publication, 7 May 2013; doi:10.1038/ajg.2013.138....
  2. Biological and physicochemical properties of two polysaccharides from the mycelia of Grifola umbellate.
    Yunpeng Bi, Ye Miao, and Qing Wang

    Carbohydr Polym 95(2):740-5 (2013) PMID 23648036

    We firstly reported the antioxidant, antitumor and immunomodulatory effects of two polysaccharides (GUMP-1-1 and GUMP-1-2) isolated from Grifola umbellata mycelia. Chemical analysis indicated that two polysaccharide fractions contained different content of neutral sugar, uronic acid and protein, as...
  3. Cyclin-dependent kinase inhibitor therapy for hematologic malignancies.
    Prithviraj Bose, Gary L Simmons, and Steven Grant

    Expert Opin Investig Drugs (2013) PMID 23647051

    Cyclin-dependent kinases (CDKs) regulate cell cycle progression. Certain CDKs (e.g., CDK7, CDK9) also control cellular transcription. Consequently, CDKs represent attractive targets for anticancer drug development, as their aberrant expression is common in diverse malignancies, and CDK inhibition ca...